Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

na's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersJack Lief

David Schull, PresidentPresident and CEO

david.schull@russopartnersllc.com858.717.2310Cindy McGeeManager, IR and Corporate Communications

Anthony J. Russo, Ph.D., CEO858.453.7200, ext. 1479

tony.russo@russopartnersllc.com212.845.4251 www.arenapharm.com Arena Pharmaceuticals, Inc.Condensed Consolidated Statements of Operations (In thousands, except per share amounts)Three months endedNine months endedSeptember 30,September 30,2010200920102009(unaudited)(unaudited)RevenuesManufacturing services

$  1,846$  1,737$  5,258$  4,663Collaborative agreements

5,7838827,3433,042  Total revenues

7,6292,61912,6017,705Operating ExpensesCost of manufacturing services

1,8141,7055,3094,702Research and development

20,15522,14758,97188,972General and administrative

6,8625,42320,63618,725Restructuring charges

———3,324Amortization of acquired technology & other intangibles

5415821,6091,721  Total operating expenses

29,37229,85786,525117,444Interest and Other Income (Expense)Interest income

10775338291Interest expense

(6,267)(7,339)(16,198)(10,991)Gain from valuation of derivative liabilities

3,0232,4724,857345Loss on extinguishment of debt

(12,354)(2,479)(12,354)(2,479)Other

968(326)988(859)  Total interest and other expense, net

(14,523)(7,597)(22,369)(13,693)Net loss

$(36,
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
... ROCKVILLE, Maryland and SURESNES, France, Dec. 1, ... biotechnology company that develops next generation antibody ... company, announced today that they have entered ... for the development and commercialization of MGA271, ...
... 2011 The U.S. Food and Drug Administration today ... Lipitor (atorvastatin calcium tablets). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... approval to make generic atorvastatin calcium tablets in 10 ... The drug will be manufactured by Ohm Laboratories in ...
Cached Medicine Technology:MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 2MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 3MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 4FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 2FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 3
(Date:7/12/2014)... The report, "Phthalic Anhydride and Derivatives ... Application & Geography – Trends & Forecast to 2018," ... forecasting of market volume and value. The report also ... The market of phthalic anhydride is projected to grow ... million by 2018, with a CAGR of 5.24% from ...
(Date:7/12/2014)... The Security Analytics market is estimated to ... by 2019, at an expected CAGR of 9.7% for ... counter the increasing number of security breaches, continued line ... systems in organizations are enormous. Vendors in the security ... architecture to develop better and more secure systems. , ...
(Date:7/12/2014)... 12, 2014 (HealthDay News) -- Burn injuries increase in the ... grills, say burn experts. Among those most vulnerable to these ... most vulnerable and often get burned by putting their hands ... director of the burn unit at Loyola University Medical Center ... "The old adage of ,When you play with fire, you ...
(Date:7/12/2014)... 2014 As DePuy Pinnacle hip lawsuits ... courts, Bernstein Liebhard LLP notes the publication of a ... the failure of metal-on-metal hip replacements. The research, which ... of Bone & Joint Surgery, looked at 597 ... prostheses at least twelve months earlier. The blood metal ...
(Date:7/12/2014)... Doylestown Hospital recently conducted an interview with ... questions. Paddock tackles topics including main men's health ... longer than men, and testosterone replacement therapy, among others. ... featured on Doylestown Hospital’s website, Dr. Brad Paddock says, ... If you notice pain, bulging, or asymmetry in your ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
... deficiencies in healthcare provision in parts of Mecklenburg-West Pomerania. ... Greifswald University and her coauthors in the current edition ... 2010; 107[18]: 328-34). They emphasize that similar trends can ... The demographic transition leads to an increase in the ...
... ... prevention of a wide range of both common and rare diseases are possible before ... ... new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is ...
... ... continues to challenge scientists. There is growing evidence that increases in protease ... team of scientists at the University of Alabama measured a common protease ... with healthy volunteers. Previous studies have shown increases in MMP-9 in CF ...
... ... Citrix and Insight Venture Partners , ... Philadelphia, PA (Vocus) May 20, 2010 -- PHD Virtual Technologies , pioneer and ... investment agreement with Citrix Systems, a leading provider of virtual computing solutions that help companies ...
... rosemary, turmeric, fingerroot inhibited production of carcinogenic compounds , ... certain spices to your burgers before tossing them on ... the flavor of the meat, but they can also ... cooking of beef. , Scientists at Kansas State University ...
... ... NanaWall Systems, Inc. announces the NanaWall SL60 is featured in the ... sponsored by the USGBC for interior designers to showcase the best ... The NanaWall connects the hotel suite to an outdoor lounge ...
Cached Medicine News:Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:News from Molecular Medicine 2Health News:PHD Virtual Technologies Announces Citrix Investment 2Health News:PHD Virtual Technologies Announces Citrix Investment 3Health News:PHD Virtual Technologies Announces Citrix Investment 4Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 3
... Hand-Held Pulse Oximeter provides SpO 2 and ... adult. The device is battery or AC ... visible and audible alarm signals, and an infrared ... rubber boot is also available for added protection. ...
... Hand-Held Pulse Oximeter with built-in Summary ... screening studies in the sleep lab, ... its easy-to-use, 2-key operation, it also ... SpO 2 , pulse rate and ...
... is a cost-effective, stand-alone monitor that delivers ... and pulse strength measurements of patients from ... battery powered unit displays a plethysmographic waveform, ... to 30 hours of on screen trended ...
... Administration (FDA) has granted approval of Alcon's ... patients with and without presbyopia. This innovative ... to give patients a full range of ... greatly increases their independence from glasses after ...
Medicine Products: